Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study

Radical radiotherapy of prostate cancer requires a relatively high dose to achieve an optimal tumor control probability and a reduced dose to the critical structures related to the sexual function (S_OARs) in order to avoid erectile dysfunction. The aim of this study was to perform a planning feasibility analysis of a 3-level dose prescription with Simultaneous Integrated Boost (SIB) on the dominant intraprostatic lesion (DIL) and with S_OARs sparing.

https://www.meddos.org/article/S0958-3947(19)30030-5/fulltext?rss=yes

Source: Medical Dosimetry - April 3, 2019 Category: Radiology Authors: Selena Ciabatti, Maria Ntreta, Milly Buwenge, Caterina Gaudiano, Elisa Sessagesimi, Fabrizio Romani, Anna L. Angelini, Silvia Cammelli, Gabriella Macchia, Francesco Deodato, Alice Zamagni, Rita Golfieri, Alessio G. Morganti, Savino Cilla Source Type: research